Assignee
FLAMEL IRELAND LTD
IE·53 granted patents·26 pending applications·993 citations·filing 2013–2025
Top patents by PatentIndex Score
79 records- 0199US11839597B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Dec 12, 2023·27 cites·30 claims
- 0299US11065224B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 20, 2021·42 cites·38 claims
- 0399US10973795B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Apr 13, 2021·48 cites·24 claims
- 0499US10952986B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Mar 23, 2021·50 cites·31 claims
- 0598US11052061B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 6, 2021·33 cites·24 claims
- 0698US11000498B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted May 11, 2021·38 cites·20 claims
- 0798USRE47084EOral medicinal product with modified release of at least one active principle in multimicrocapsular formFLAMEL IRELAND LTD·Filed 2016·Granted Oct 16, 2018·36 cites·74 claims
- 0898US9814684B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL IRELAND LTD·Filed 2015·Granted Nov 14, 2017·36 cites·31 claims
- 0997US12128021B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Oct 29, 2024·12 cites·26 claims
- 1097US12097175B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·9 cites·30 claims
- 1197US11986451B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted May 21, 2024·24 cites·26 claims
- 1297US11504347B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Nov 22, 2022·38 cites·25 claims
- 1397US10736866B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Aug 11, 2020·53 cites·52 claims
- 1497US10272062B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2017·Granted Apr 30, 2019·68 cites·89 claims
- 1596US12257223B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 25, 2025·2 cites·14 claims
- 1696US12138239B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 12, 2024·9 cites·30 claims
- 1796US12115145B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·29 claims
- 1896US12115144B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·15 claims
- 1996US12115143B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·26 claims
- 2096US12115142B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·30 claims
- 2196US11896572B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Feb 13, 2024·28 cites·1 claims
- 2296US11826335B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 28, 2023·27 cites·10 claims
- 2396US11766418B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Sep 26, 2023·27 cites·11 claims
- 2496US11602512B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·11 claims
- 2596US11602513B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·27 claims
- 2696US11583510B1Methods of administering gamma hydroxybutyrate formulations after a high-fat mealFLAMEL IRELAND LTD·Filed 2022·Granted Feb 21, 2023·37 cites·14 claims
- 2795US12226388B2Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·2 cites·29 claims
- 2895US11779557B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Oct 10, 2023·7 cites·6 claims
- 2995US11400065B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2020·Granted Aug 2, 2022·37 cites·110 claims
- 3095US10925844B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2020·Granted Feb 23, 2021·51 cites·29 claims
- 3195US10092511B2Controlled-release floating pharmaceutical compositionsFLAMEL IRELAND LTD·Filed 2016·Granted Oct 9, 2018·43 cites·23 claims
- 3294US12263150B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·19 claims
- 3394US12263151B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·15 claims
- 3494US12239625B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 4, 2025·1 cites·15 claims
- 3594US12226389B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·1 cites·14 claims
- 3694US12186298B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Jan 7, 2025·1 cites·26 claims
- 3794US12109186B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 8, 2024·1 cites·11 claims
- 3894US10543186B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Jan 28, 2020·20 cites·28 claims
- 3994US10493051B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Dec 3, 2019·22 cites·27 claims
- 4094USRE46686EPharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsFLAMEL IRELAND LTD·Filed 2016·Granted Jan 30, 2018·36 cites·74 claims
- 4194US2026097010A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 4293US12186296B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Jan 7, 2025·2 cites·63 claims
- 4392US12167991B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted Dec 17, 2024·1 cites·23 claims
- 4492US2026014111A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 4591US12303478B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted May 20, 2025·1 cites·30 claims
- 4691US12167992B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted Dec 17, 2024·1 cites·26 claims
- 4789US12144793B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 19, 2024·0 cites·23 claims
- 4889US12097176B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·0 cites·6 claims
- 4989US2024366548A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
- 5086US2026091013A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when FLAMEL IRELAND LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →